Thomas Blevins
-
- Diabetes Management and Research 37
- Diabetes Treatment and Management 36
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 8
- Pharmacology top 2%
- Pharmacology and Obesity Treatment 3
- Surgery top 5%
- Pancreatic function and diabetes 17
- Genetics top 5%
- Diabetes and associated disorders 12
- Family Practice top 10%
-
- Metabolism, Diabetes, and Cancer 15
-
- Biosimilars and Bioanalytical Methods 3
Thomas Blevins
54 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 2.3k
- Pharmacology 441
- Surgery 954
- Genetics 444
- Family Practice 24
Countries citing papers authored by Thomas Blevins
This map shows the geographic impact of Thomas Blevins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Blevins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Blevins more than expected).
Fields of papers citing papers by Thomas Blevins
This network shows the impact of papers produced by Thomas Blevins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Blevins. The network helps show where Thomas Blevins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Blevins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 0 | |
| 7 | 2022 | 5 | |
| 8 | American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitusbreakdown → | 2021 | 179 |
| 9 | 2020 | 8 | |
| 10 | 2020 | 30 | |
| 11 | 2018 | 34 | |
| 12 | Hot Topics in Primary Care: Demystifying the Differences: Follow-on Biologics, Biosimilars, and Generics. | 2017 | 1 |
| 13 | 2016 | 2 | |
| 14 | 2014 | 321 | |
| 15 | 2014 | 95 | |
| 16 | 2011 | 74 | |
| 17 | 2010 | 23 | |
| 18 | 2010 | 18 | |
| 19 | 2010 | 8 | |
| 20 | 2004 | 34 |
About Thomas Blevins
Thomas Blevins is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (37 papers), Diabetes Treatment and Management (36 papers), Pancreatic function and diabetes (17 papers), Metabolism, Diabetes, and Cancer (15 papers), Diabetes and associated disorders (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers), Pharmacology and Obesity Treatment (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Pharmacology (441 citations) and Surgery (954 citations). Thomas Blevins has collaborated with scholars based in United States, India and Germany. Frequent co-authors include George Grunberger, Julio Rosenstock, Ping Yan, Kristin Taylor, Michael Trautmann, John Pullman, Lisa A. Porter, Christine T. Schulteis, Jaret Malloy and Richard F. Arakaki. Their work appears in journals such as Diabetes Obesity and Metabolism, Endocrine Practice, Diabetes Care, Diabetes Technology & Therapeutics and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.